UniProtKB/SwissProt variant VAR

Variant information

Variant position:

46

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Tyrosine (Y) at position 46 (S46Y, p.Ser46Tyr).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from small size and polar (S) to large size and aromatic (Y)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In MFM1.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs60794845 [ dbSNP | Ensembl ]

Sequence information

Variant position:

46

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

470

The length of the canonical sequence.

Location on the sequence:

LGSPLSSPVFPRAGFGSKGS S SSVTSRVYQVSRTSGGAGGL

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LGSPLSSPVFP-RAGFGSKG-SSSSVTSRVYQVSRTSGGAGGL

Mouse                         LGSPLSSPVFP-RAGFGTKG-SSSSMTSRVYQVSRTSGGAG

Rat                           LGSPLSSPVFP-RAGFGTKG-SSSSVTSRVYQVSRTSGGAG

Pig                           LGSPLSSPVFP-RAGFGTKG-SSSSVTSRVYQVSRTSGGAG

Bovine                        LGSPLSSPVFP-RAGFGTKG-SSSSVTSRVYQVSRTSGGAG

Chicken                       -----TSPVFP-RASFGSRG-SGSSVTSRVYQVSRTSA-VP

Xenopus laevis                ------SPSFSTRSSFGSKGASSSSVSSRVYQVSRSTA-AP

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 470	Desmin
Region	2 – 108	Head
Modified residue	28 – 28	Phosphoserine; by CDK1
Modified residue	31 – 31	Phosphoserine
Modified residue	32 – 32	Phosphoserine; by CDK1
Modified residue	37 – 37	Asymmetric dimethylarginine; alternate
Modified residue	37 – 37	Omega-N-methylarginine; alternate
Modified residue	45 – 45	Phosphoserine
Modified residue	58 – 58	ADP-ribosylarginine
Modified residue	60 – 60	Phosphoserine; by AURKB

Literature citations

Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.
Selcen D.; Ohno K.; Engel A.G.;
Brain 127:439-451(2004)
Cited for: VARIANTS MFM1 ILE-2; TYR-46; PHE-46 AND THR-449;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P17661: Variant p.Ser46Tyr